The field demonstrates a clear trend from GLP-1 agonists towards dual and triple receptor agonists, with research heavily published in high-impact journals and led by US-based, multi-author teams.
← all excerpts
A Bibliometric Analysis Review of the Top 50 Most Cited Articles on Incretin-Based Therapy for Weight Reduction and Diabetes Management.
1
—
—